William Harnisch’s Antares Pharma, Inc. ATRS Stock Holding History

William Harnisch’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,000	Closed	-$91K	–	54
2021 Q3	$91K	Hold	25,000	–	–	0.01%	46
2021 Q2	$109K	Hold	25,000	–	–	0.01%	46
2021 Q1	$103K	Hold	25,000	–	–	0.01%	52
2020 Q4	$100K	Hold	25,000	–	–	0.01%	62
2020 Q3	$68K	Hold	25,000	–	–	0.01%	44
2020 Q2	$69K	Hold	25,000	–	–	0.02%	50
2020 Q1	$59K	Hold	25,000	–	–	0.02%	44
2019 Q4	$118K	Hold	25,000	–	–	0.02%	52
2019 Q3	$84K	Hold	25,000	–	–	0.02%	47
2019 Q2	$82K	Hold	25,000	–	–	0.02%	50
2019 Q1	$76K	Buy	+25,000	New	+$81K	0.02%	49

Other funds holding ATRS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

William Harnisch's ATRS Position: Q4 2021 in Review

William Harnisch sold out of Antares Pharma, Inc. (ATRS) in Q4 2021, closing a stake of 25,000 shares — an estimated $91K sold.

William Harnisch first reported a position in ATRS in Q1 2019 and held it in 11 quarters. The position peaked at $118K in Q4 2019. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

William Harnisch reported no remaining Antares Pharma, Inc. position as of Q4 2021 after selling out during the quarter.
William Harnisch sold 25,000 Antares Pharma, Inc. shares in Q4 2021, an estimated $91K.
William Harnisch first reported a position in Antares Pharma, Inc. in Q1 2019 and held it in 11 quarters.
William Harnisch's Antares Pharma, Inc. position peaked at $118K in Q4 2019.
162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on Peconic Partners's 13F filing for Q4 2021, filed 14 Feb 2022.